Depressive Disorder

Features

Pharmacogenetic Testing: Does it Improve Therapy in Patients With MDD?

By

Lauren Nolan, MMSc, PA-C

Tia M. Solh, MT (ASCP), MSPAS, PA-C

Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.

Latest News

“Real-Life” Activities Lead to Happier Teens

By

Heather R. Johnson

This study examines adolescents’ recreational screen time and participation in extracurricular activities during after-school hours in association to indicators of positive and negative mental health and wellbeing.

Acne Significantly Impacts Mental Health, Emphasizing Need for More Holistic Approaches to Treatment

By

Brandon May

Clinicians should consider a holistic approach that focuses on how acne effects quality of life (QoL), relationships, and self-image.

Outcomes Vary for Depression Collaborative Care Programs

Real-world collaborative care programs for depression show large variation in clinical outcomes.

Receipt of Disability Services Elevated in Individuals With Mood Disorders

By

Rose Reeb

Investigators looked into the risks of receiving disability services after a first diagnosis of mood or common mental disorder.

Amyloid Deposition and Depression in People Without Dementia

By

Heather R. Johnson

This study aimed to examine the association between cortical Aβ deposition and depressive and anxiety symptoms, and between Aβ deposition in the amygdala, striatum, and thalamus and depressive and anxiety symptoms.

Statin Use Not Correlated With Anxiety Disorders, Seizures, or Suicidality, But May Increase Depressive Disorders

By

Jessica Nye, PhD

While statins have both good and bad outcomes in the realm of neuropsychiatry, researchers looked at the possible associations with statins and suicidality, depression, anxiety, and seizures.

Significant Depression Symptoms More Frequent Than Clinically Diagnosed Depression in Patients With RA

By

Mary Beth Maslowski

Researchers examined the prevalence of depression symptoms compared to clinically diagnosed depression, as well as the association of depression with mortality in patients with rheumatoid arthritis.

COVID-19 Patients With Longer Hospital Stays May Have Better Psychiatric Outcomes

By

Mary Stroka

Researchers conducted 1-month follow-ups with patients who had either been treated at the hospital or at home for COVID-19 and found that longer hospital stays were associated with lower scores on psychopathology dimension tests.

Psychosocial and Health Factors Increased Risk for Severe Depression During the COVID-19 Pandemic

By

Jessica Nye, PhD

Right now, the wellbeing among high-risk groups during the COVID-19 pandemic is an immediate research priority.

Expert Q&A: Opioid-Based Therapies for Major Depressive Disorder

By

Tori Rodriguez, MA, LPC, AHC

An estimated 30% of patients who are prescribed antidepressant medications do not have an adequate response. In order to address these high rates of nonresponse to standard depression therapies, researchers continue to explore a wide range of other promising agents, including anti-inflammatory therapies and psilocybin.